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The importance of antibody and CD8/ cells in resolution of murine rotavirus (EDIM) infection and protection against
reinfection was examined with two strains of B-cell-deficient mice. Following inoculation of one strain (JHD), rotavirus infection
was resolved within days, but when later reinoculated with EDIM, these mice again shed rotavirus. Thus, effector mechanisms
other than antibody resolved viral shedding in JHD mice but were insufficient to prevent reinfection. EDIM shedding in
another B-cell-deficient mouse strain (mMT) diminished but was not fully resolved 93 days after the initial infection, thus
demonstrating that antibody could also be important in resolution of rotavirus infection. When depleted of CD8/ cells by
monoclonal antibody treatment before EDIM inoculation, JHD mice were unable to resolve shedding. Even though mMT mice
did not fully resolve their initial infection, depletion of CD8/ cells 49 days after initial inoculation resulted in a burst of
shedding. Thus, CD8/ cells were involved in resolution of the initial EDIM infection in both strains of B-cell-deficient mice.
Finally, when mMT mice were depleted of CD8/ cells before the initial EDIM infection, gradual resolution of rotavirus
shedding was still observed, suggesting a third effector mechanism was also involved in resolution of rotavirus infection
in mice. q 1995 Academic Press, Inc.
INTRODUCTION ally or orally with homologous or heterologous rotavi-
ruses results in large rotavirus antibody responses and
Rotaviruses are the primary cause of severe infantile
measurable cytotoxic T lymphocyte (CTL) activity against
viral gastroenteritis. Acute rotavirus disease is self-lim-
syngenic rotavirus-infected target cells (Offit and Dudzik,
iting and resolution of symptoms normally occurs within
1988; Offit and Dudzik, 1989). Passive transfer of rotavirusa few days. Infected subjects may be protected against
antibody from immunized dams to suckling pups throughsubsequent episodes of serious rotavirus disease
breast milk has been found to provide serotype-specific(Bishop et al., 1983; Reves et al., 1989; Coulson et al.,
protection of pups against rotavirus diarrhea (Offit and1992) and, in some cases, have remained free of rotavi-
Clark, 1985; Offit et al., 1986). Likewise, resolution ofrus infection for extended times (Bernstein et al., 1991;
rotavirus infection and protection against rotavirus dis-Ward and Bernstein, 1994). The immune mechanisms
ease have been reported following passive administra-responsible for resolution of the infection and protection
tion of rotavirus-specific CD8/ cells. Adoptive transfer ofagainst subsequent rotavirus illnesses are not well un-
CD8/ spleen cells from immunized mice into syngenicderstood. Correlations between protection and either se-
pups prior to rotavirus inoculation protected against diar-rum or intestinal rotavirus antibody titers have been re-
rhea (Offit and Dudzik, 1990), and immune CD8/ cellsported (Kapikian et al., 1983; Ryder et al., 1985; Chiba et
adoptively transferred into mice with severe combinedal., 1986; Ward et al., 1989; Clemens et al., 1992; O’Ryan
immunodeficiency were able to resolve chronic rotaviruset al., 1994), but these correlations have not been consis-
infections which had been established in these immuno-tently observed (Ward and Bernstein, 1995). The impor-
deficient mice (Dharakul et al., 1990). Thus, mice couldtance of immunological effectors other than antibody in
be protected by passive transfer of either rotavirus anti-either resolution or prevention of rotavirus infection in
body or CD8/ cells from immunized mice. However, thehumans is unknown. Therefore, animal models were de-
importance of either effector arm in active immunity inveloped to gain an understanding of the immune mecha-
mice has not been clarified.nisms against rotavirus disease.
To determine the immune responses involved in activeDue to the relative simplicity of the model, many stud-
immunity, we developed an adult mouse model (Ward eties on the mechanism of immunity to rotavirus have been
al., 1990). Although oral administration of murine rotavi-conducted with mice. Inoculation of mice either parenter-
rus to adult mice does not induce diarrhea, naive mice
of all ages become infected when inoculated. Thus, the1 To whom reprint requests should be addressed at Division of Infec-
model involves protection against infection rather thantious Diseases, Childrens Hospital Research Foundation, 3333 Burnet
Avenue, Cincinnati, OH 45229-3039. against illness. Murine rotavirus infection in normal mice,
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as determined by viral shedding, persists for up to ap- cysts from C57BL/6 mice, and the derived offspring were
backcrossed multiple times to C57BL/6 mice. These miceproximately 10 days, and once infection is resolved, mice
are protected for their lifetimes against subsequent infec- containing a mMT mutation on a C57BL/6 background
were purchased (females only) from Jackson Labora-tion with the homologous virus (McNeal and Ward, 1995).
Protection in these mice has been correlated with titers tories (Bar Harbor, ME) and used when 6–10 weeks of
age. They were included in this study with permission ofof serum and stool rotavirus IgA, suggesting that anti-
body was involved (McNeal et al., 1994; Feng et al., 1994). K. Rajewsky. Both mMT and JHD mice were found to pro-
duce no detectable amounts of antibody.However, no association has been found between pro-
tection and serotype-specific neutralizing serum or intes-
Rotavirus straintinal antibody (Ward et al., 1992; McNeal et al., 1992).
Thus, if antibody is responsible for protection, the mecha- Mouse rotavirus (EDIM), originally obtained in 1980
from M. Collins (Microbiological Associates, Bethesda,nism may not be by classical neutralization. Very recently
it has been reported that inoculation of mice with hybrid- MD), was used to orally inoculate neonatal BALB/c mice
to produce large quantities of non-tissue-culture-adaptedoma cells producing monoclonal antibodies of the IgA
subtype against the VP6 protein of rotavirus prevented rotavirus. Stools collected twice daily from mice with diar-
rhea were initially diluted in Earles balanced salt solutionrotavirus infection in adult mice (Siadatpajouh et al.,
1995). This finding was the first to provide evidence for (EBSS) and frozen. Later they were thawed, combined,
mixed with an equal (50-ml) volume of cold geneton,a functional role of nonneutralizing antibody in prevention
of rotavirus infection. and blended. After collection of the aqueous phase, the
geneton phase was reextracted by blending with anotherThe purpose of this study was to determine the involve-
ment of rotavirus antibody and viral specific CD8/ cells 50 ml of EBSS, and the combined aqueous phases were
centrifuged (SW27, 20,000 rpm, 90 min, 57) to pellet virus.in resolution of rotavirus infection and in active immunity
against reinfection. For this study, two strains of geneti- The virus was resuspended in 40 ml of medium (Dulbec-
co’s modified MEM) and stored frozen in 0.5-ml aliquotscally engineered mice that were incapable of producing
functional antibody were inoculated with a murine rotavi- containing 1 1 107 focus-forming units (ffu)/ml.
rus and, if the infection was resolved, later reinoculated
Study planwith the same virus. In this way, the importance of anti-
body in resolution of rotavirus infection and prevention The experiments in this study were divided into two
parts: oral inoculation of mice with EDIM and reinoculationof subsequent infection could be definitively determined.
In addition, mice were depleted of CD8/ cells either prior 6–12 weeks later with this same virus. On the day of each
inoculation and for specified days thereafter, two stoolto their initial inoculation or just before challenge to de-
termine the possible involvement of these cells in resolu- pellets per day were collected from each mouse and
placed in 0.5 ml of EBSS before being frozen. These weretion and prevention of rotavirus infection.
later homogenized and tested for rotavirus antigen by an
enzyme-linked immunosorbent assay (ELISA). For deple-MATERIALS AND METHODS
tion of CD8/ cells, mice were injected intraperitoneally
Mouse strains
(ip) once per day with 1 mg of an ammonium sulfate-
precipitated anti-CD8/ monoclonal antibody (mAb) ob-Two strains of genetically engineered mice which
were unable to produce functional antibody were used in tained from the rat hybridoma cell line 2.43 purchased
from the American Type Culture Collection. The 2.43 mAbthis study. The first were JHD mice which cannot produce
functional Ig heavy-chain because of a targeted deletion belongs to the IgG2b subset and is reactive with the Lyt
2.2 antigen on the surface of CD8/ cells. mAb injectionsof the JH gene segments in embryonic stem cells (Chen
et al., 1993). These mice are devoid of surface Ig/ cells were initiated 4 days before an EDIM inoculation and
performed for 4 consecutive days and twice weekly there-as a result of blockage of B cell differentiation at the
large CD43/ precursor stage. Agouti JHD mice were de- after for 3 additional weeks unless otherwise indicated.
Analyses by a fluorescence-activated cell sorter (FACS)rived after AB-1 ES stem cells containing the JH deletion
were injected into C57BL/6J blastocysts. Breeding pairs were performed either on the day of viral inoculation or
at times specified for each experiment to determine theof JHD mice were generously provided by D. Huszar of
GenPharm International (Mountain View, CA). Experi- percentages of CD8/ cell depletion in different lymphoid
tissues. Following oral inoculation of EDIM, mice werements were conducted with adult (6–20 weeks of age)
or neonatal (4-day-old) mice. monitored for shedding as described above to determine
the effects of CD8/ cell depletion.The second mouse strain was produced by Kitamura
et al. (1991) by targeted disruption of a membrane exon
Measurement of rotavirus sheddingof the gene encoding the m-chain constant region (mMT
mutation) in mouse embryonic stem cells. The Fecal specimens collected before and after EDIM inoc-
ulation were examined for the presence of rotavirus anti-transfected stem cell clone D3 was injected into blasto-
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gen using an ELISA as previously described (McNeal et the process was repeated. A total of three incubations
with dispase were performed to fully digest the intestineal., 1994). The absorbency values represent the average
of two negative coated wells subtracted from the average and isolate LP cells. Collected medium was combined
and centrifuged (10 min, 200 g). The cells were resus-of the two positive coated wells. Final absorbencies were
considered positive if the positive wells were two times pended in 40% Percoll and layered onto a 70% Percoll
cushion. The gradient was centrifuged (30 min, 1000 g),the negative wells and ¢0.15. The A490 values obtained
were used not only to demonstrate the presence or ab- and the lymphocytes were isolated from the interface.
LP cells were washed in RPMI / 2% FBS.sence of virus, but also to quantify the amount of viral
shedding. When the readings were¢3.0 (maximum read-
FACS analysising), the specimen was assigned a value of 4.0 for calcu-
lation purposes. Spleen, MLN, IEL, and LP cells were counted and re-
suspended at a density of 107 cells per milliliter in Dul-
Isolation of lymphoid tissues becco’s phosphate-buffered saline containing 0.1% so-
dium azide and 0.1% gelatin (DPBS/). Before staining
For FACS analysis, control and CD8/-depleted animals with conjugated antibody, spleen cells were incubated
were sacrificed. Spleen and mesenteric lymph nodes (30 min, 47) with normal rat IgG (Sigma) and washed with
were removed and single cell suspensions were pre- DPBS/. Cells were incubated with R-phycoerythrin (PE)-
pared in RPMI medium (Gibco) / 2% fetal bovine serum conjugated anti-CD4/ mAb clone RM4-4 (Pharmingen)
(FBS). The small intestine was removed and placed in a and fluorescein isothiocyanate (FITC)-conjugated anti-
petri dish containing RPMI / 2% FBS. JHD and mMT mice CD8/mAb clone 53-6.7 (Pharmingen) to determine CD4/
did not have visible Peyer’s patches. To isolate intraepi- and CD8/ cell populations. Cells were also stained with
thelial (IEL) and lamina propria (LP) lymphocytes from PE-conjugated anti-mouse CD3 mAb clone 29B (Sigma)
the small intestine, mesenteric tissue and connective and FITC-conjugated anti-mouse CD45R/B220 mAb
tissue were dissected from the small intestine. The intes- clone RA3-6B2 (Pharmingen) to determine total T and B
tine was cut horizontally and washed twice in RPMI. To cells, respectively. Cells were stained (30 min, 47) and
isolate IELs, the intestine was then cut in pieces approxi- washed two times with DPBS/. Cells were finally resus-
mately 1 cm in length, placed in a flask with 40 ml of pended in PBS / 1% formaldehyde. Flow cytometry was
RPMI / 2% FBS, and incubated (377, 2 min) while stirring performed with a Coulter EPICS Profile II Analyzer.
at a medium speed. After incubation, the intestinal pieces
were strained, and the medium was collected and held Statistical analyses
on ice. The intestinal pieces were placed in a 50-ml
Differences in shedding between groups of mice weresterile conical tube with 15 ml of RPMI (no FBS) and
determined by a paired Student t test using the averagevigorously shaken for 15 sec. After shaking, the medium
A490 values obtained by ELISA for each mouse within awas strained and combined with the 40 ml collected
group on each day the comparison was made.previously. The intestinal pieces were shaken a total of
three times, and all medium was combined and centri-
RESULTSfuged (10 min, 200 g) to pellet the cells. The cell pellet
was resuspended in RPMI / 2% FBS and then passed Resolution of EDIM infection in JHD micethrough a column loosely packed with glass wool. Pro-
cessing of the intestinal pieces was repeated an addi- The initial experiment was to determine whether rota-
virus infection could be resolved in B-cell-deficient JHDtional two times, including steps from incubation in 40
ml of RPMI / 2% FBS to passage through the glass wool mice. Oral inoculation with 5 1 105 ffu of unpassaged
murine rotavirus strain EDIM produced infection in 14column. Cells from the three columns were combined
and centrifuged (10 min, 200 g). The cell pellet was resus- of 14 adult JHD mice based on viral shedding in fecal
specimens. Although the greatest number of mice shedpended in 40% Percoll (Pharmacia) and layered onto a
70% Percoll cushion. The gradient was centrifuged (30 detectable virus 1 day after inoculation, peak shedding
as determined by optical density measurements oc-min, 1000 g), and the lymphocytes were collected from
the interface. IELs were washed in RPMI / 2% FBS. curred between 2 and 6 days, and no shedding was
detected beyond 10 days (Fig. 1). Viral shedding wasTo isolate the laminia propria lymphocytes, the intesti-
nal pieces collected as described above were minced detected for a minimum of 1 day and for a maximum of 10
days with an average of 5.9 days/mouse. This sheddingand 15 ml of S-MEM-Joklik’s modified medium (Gibco)
containing 1.5 mg/ml of Dispase Grade II (Boehringer- pattern was very similar to that found in normal BALB/c
mice (Ward et al., 1990). Thus, adult JHD mice could beMannheim) was added. These intestinal pieces were
then incubated (15 min, 377) with slow stirring. The intes- readily infected with EDIM, and their inability to produce
antibody did not prevent them from resolving rotavirustinal pieces were strained, and the medium collected
was held on ice. Fresh dispase was added (15 ml) and infection within a normal time.
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TABLE 1
Shedding of Rotavirus in JHD Mice When Challenged with EDIM
either 6 or 12 Weeks after Inoculationa
6 weeks 12 weeks
Number of mice 5 6
Number of mice shedding virus 4 (80%) 4 (67%)
Average number of days of viral shedding 3.5 3.0
Range of days of viral shedding 1–9 1–9
Average quantity of virus shedb 0.424c 0.364
a JHD mice immunized by oral inoculation with unpassaged EDIM
were challenged with this same virus at the same dose (5 1 105 ffu)
at the times specified after the initial inoculation.
b Quantity defined by average A490 values above background perFIG. 1. Rotavirus shedding in JHD mice following an initial EDIM
mouse per day for all mice within each group. Average is based oninoculation. JHD mice were orally inoculated with 5 1 105 ffu of EDIM,
shedding during the 9 days after challenge for both groups. Absorben-and stools collected on the day of inoculation (Day 0) and for the
cies were determined by ELISA.following 14 days were tested for rotavirus antigen by ELISA. The A490
c Not significantly different from that found after 12 weeks but signifi-values are the averages obtained each day from 14 mice. Percentage
cantly less (P  0.03) than that found after the initial EDIM inoculation.values are the percentages of mice shedding detectable rotavirus anti-
gen each day after inoculation.
after the initial inoculations, detectable shedding oc-
To determine whether neonatal mice with immature curred with every challenge except in mouse B after the
immune systems could also resolve EDIM infections, 4- third challenge (Fig. 2). Thus, JHD mice could be rein-
day-old JHD mice were inoculated with 2 1 104 ffu of fected multiple times with EDIM, and the infection was
EDIM. All three inoculated mice experienced diarrhea resolved after each infection.
beginning on the second day after inoculation, and diar-
Effect of CD8/ cell depletion on EDIM sheddingrhea persisted for up to 10 days (results not shown) as
in JHD micehas been previously found for rotavirus diarrhea in nor-
mal mice (Ward et al., 1990). Viral shedding became un- To determine the importance of CD8/ cells in resolu-
detectable between 16 and 19 days after inoculation. tion of an initial or subsequent EDIM infection in JHD
Thus, neonatal JHD mice were also able to resolve EDIM mice, these cells were depleted with anti-CD8/ cell
infections in the absence of antibody production. monoclonal antibody 2.43. Intraperitoneal mAb injection
was begun 4 days before either the initial EDIM inocula-
Reinfection of JHD mice with EDIM tion or the EDIM challenge, performed daily until the day
At either 6 or 12 weeks after their initial inoculations of EDIM inoculation, and continued twice weekly for an
with EDIM, JHD mice were orally challenged with 5 1 105 additional 3 weeks. FACS analysis conducted at the time
ffu of EDIM. Most mice again shed rotavirus, and the
quantity of rotavirus shed and average days of shedding
were not significantly (P  0.1) different between the
groups challenged at 6 or 12 weeks (Table 1). At both
times, viral shedding was resolved by 10 days after chal-
lenge. Although the period of viral shedding followed
the same pattern as that found after the initial EDIM
inoculations, there was significantly (P 0.03) less shed-
ding after challenge, and 3 of 11 mice (27%) did not shed
detectable amounts of rotavirus when challenged. Thus,
unlike immunologically normal mice which were com-
pletely resistant to reinfection with EDIM (Ward et al.,
1990; McNeal and Ward, 1995), B-cell-deficient JHD mice
were susceptible to EDIM reinfection within 5 weeks or
FIG. 2. Shedding of rotavirus following an initial EDIM infection andless after resolving their initial infections.
after repetitive challenges of JHD mice. Two mice (A and B) were inocu-To determine whether JHD mice could be reinfected
lated with EDIM (5 1 105 ffu), and the average A490/day of rotaviruswith EDIM multiple times, two mice were challenged
antigen determined by ELISA was measured for the next 10 days for
either three or four times with 6-week periods between each mouse. At 6-week intervals, the mice were again inoculated with
inoculations. Although the quantity of virus shed was 5 1 105 ffu of EDIM (three times for mouse A and four times for mouse
B), and average A490/day was determined in the same manner.generally reduced upon challenge relative to that found
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TABLE 2 ignated mMT. Following their initial inoculation with
EDIM, mMT mice all (15/15) shed rotavirus and, like JHDDepletion of CD8/ Cells in Different Lymphoid Tissues of JHD Mice
mice, appeared to resolve their infections by approxi-by Intraperitoneal mAb Injection as Determined by FACS Analysisa
mately 10 days (Fig. 5A). However, without reinoculation
% CD8/ cells with EDIM, a second wave of viral shedding occurred;
even up to at least 93 days after EDIM inoculation, spo-
Control mice Depleted mice
radic rotavirus shedding was observed in these mice.Lymphoid tissue (N  2) (N  2) % depletion
Thus, rotavirus shedding after the initial inoculation with
Spleen 39 0.7 98.2 EDIM in mMT mice diminished very slowly and was still
Mesenteric lymph nodes 34 0.1 99.7 incomplete by 3 months after inoculation.
Lamina propria 4 0.3 92.5 At 49 days after the initial EDIM inoculation, a group
Intraepithelial lymphocytes 52 4.1 92.1
of five mMT mice was depleted of CD8/ cells by injec-
tion with mAb 2.43. As was found with JHD mice, 90%a Mice were depleted of CD8/ cells by ip injection with purified
mAb 2.43 for 4 days prior to collection of tissue specimens and FACS of CD8/ cells were depleted within 4 days by this treat-
analyses. ment. Within 2 – 3 days after depletion was initiated, ro-
tavirus shedding in these mMT mice (Fig. 5B) was signif-
icantly increased relative to that found in the nonde-
of EDIM inoculation showed 90% reduction of CD8/ pleted controls (Fig. 5A). However, even though
cells in lymphoid tissues at intestinal as well as at sys- depletion with mAb 2.43 was continued for an additional
temic sites (Table 2). 3 weeks, shedding gradually diminished but remained
CD8/ cell depletion prior to the initial EDIM inoculation significantly elevated relative to that in nondepleted
had a dramatic effect on viral shedding. None of the mice for at least 7 weeks following the initiation of CD8/
four depleted mice resolved their infections during the cell depletion. FACS analyses showed that CD8/ cells
subsequent 45 days (Fig. 3), and one mouse shed large
were still 90% depleted in all lymphoid tissues exam-
amounts of rotavirus every day during this period. The
ined at 4 weeks after mAb injections were discontinued
quantity of virus shed for the first 5 days after inoculation
in these mMT mice.
was comparable to that found in nondepleted JHD mice, The final experiment was performed to determine if
but nondepleted mice subsequently resolved their infec-
depletion of CD8/ cells prior to the initial EDIM inocula-
tions and did not shed further detectable amounts of
tion of mMT mice inhibited the gradual resolution of
rotavirus unless reinoculated (Fig. 3). FACS analysis con-
rotavirus shedding observed in nondepleted mice. Al-
ducted 57 days after EDIM inoculation of depleted mice
though CD8/ cell depletion resulted in significantly (Pshowed CD8/ cells remained 90% depleted even
though injections with mAb had been discontinued 35
days earlier. Thus, the ability to resolve EDIM infection
in JHD mice following their initial rotavirus inoculation
correlated with the presence of CD8/ cells.
Depletion of CD8/ cells just prior to EDIM challenge
at 6 weeks after the initial EDIM infection had a very
different outcome. In this case, the second infection
was resolved as rapidly in CD8/-depleted mice (Fig. 4B)
as in nondepleted animals (Fig. 4A), and the relative
quantity of viral shedding was also no greater than that
in the nondepleted mice. FACS analysis showed CD8/
cells were depleted to the same extent in this experi-
ment as was found when depletion was performed be-
fore the initial EDIM inoculation (results not shown).
Therefore, resolution of EDIM infection following reinoc-
ulation did not correlate with the presence of CD8/ cells
FIG. 3. Shedding of rotavirus following EDIM inoculation of nonde-in JHD mice.
pleted (control) and CD8/-cell-depleted JHD mice. Depletion with mAb
2.43 was initiated 4 days before inoculation of four JHD mice by ipShedding of EDIM in nondepleted mMT mice or after
injection with 1 mg of purified antibody. mAb injections were performedCD8/ cell depletion daily until the day before inoculation with 5 1 105 ffu of EDIM (Day 0)
and twice weekly for the 3 weeks following viral inoculation. StoolsTo determine if the pattern of EDIM shedding observed
were collected each day for 45 days from these and five nondepleted
in JHD mice was representative of that which occurs in control mice inoculated with EDIM on Day 0. Shedding of rotavirus
mice in the absence of antibody, the experiments were antigen was determined by ELISA, and the average A490/mouse/day
within each group was calculated daily.repeated with another strain of B-cell-deficient mice des-
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FIG. 4. Effect of CD8/ cell depletion on rotavirus shedding when performed just before a second EDIM inoculation in JHD mice. Two groups of
five JHD mice were inoculated with EDIM (5 1 105 ffu) on Day 0. Approximately 6 weeks later, the mice in one group (B) were depleted of CD8/
cells by ip injection with mAb 2.43 (1 mg). mAbs were injected for 4 consecutive days, and then the mice were challenged with 5 1 105 ffu of EDIM
on the next day (Day 0). Nondepleted mice (A) were challenged on the same day. mAb injections were continued twice weekly in the depleted
mice for a total of 3 weeks. Average shedding of rotavirus antigen/mouse/day (A490) was determined by ELISA for 14 days with both groups of mice
after each EDIM inoculation.
 0.01) greater shedding relative to that in nondepleted tinued (Fig. 6). FACS analyses revealed that CD8/ cells
remained 90% depleted throughout this 7-week stoolanimals during Week 3 after EDIM inoculation, shed-
ding in depleted mice was no greater during the other collection period. Therefore, immunological compo-
nents other than CD8/ cells appeared to be able toweeks up through Week 7 when collection was discon-
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FIG. 5. Shedding of rotavirus in mMT mice after a single EDIM inoculation and the effect of CD8/ cell depletion at 49 days after virus inoculation.
Mice (five/group) were inoculated with 5 1 105 ffu of EDIM (Day 0), and shedding of rotavirus in stool was determined for each day for 99 days by
ELISA. Average shedding/mouse/day (A490) within both groups was calculated. On Day 49 after virus inoculation, mice in one group (B) were injected
ip with 1 mg of mAb 2.43. mAb injections were performed each day for 4 days, and then twice weekly for 3 weeks. The effect of mAb injections on
shedding of rotavirus was determined by comparison with nondepleted mice (A). Significant differences in average shedding/mouse/day determined
on a weekly basis were found during Week 1 (P  0.02), Week 2 (P  0.03), and Week 7 (P  0.008) after CD8/ cell depletion was begun.
cause the gradual but inefficient resolution of EDIM priority, rotavirus vaccines developed to date have been
only partially protective, and none are yet licensed forshedding in mMT mice.
general use. Understanding the immunological mecha-
nisms of resolution of rotavirus infection and protectionDISCUSSION
against subsequent infection will provide a rational basis
for development of more effective rotavirus vaccines. TheAlthough prevention of rotavirus disease through vac-
cination has for years been an international public health active immunity model of adult mice was developed as
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Another method used to define important immunologi-
cal components is depletion of effector cells or mole-
cules by treatment with specifically targeted monoclonal
antibodies (Cobbold et al., 1984; Staats et al., 1991). To
determine the importance of CD8/ cells in overcoming
and preventing rotavirus infection, mice were treated with
an anti-CD8/ cell mAb. This treatment caused a 90%
decrease in CD8/ cells in all lymphoid tissue examined,
including intestinal IELs, in both strains of genetically
altered mice used in this study. The depletion levels at-
tained were comparable to those found at mucosal sites
with mAbs directed at other cell surface proteins (Hey-
worth et al., 1987; Mega et al., 1991). Using B-cell-defi-
cient mice depleted of CD8/ cells, it was possible to
analyze the importance of CD8/ cells in rotavirus immu-
nity when antibody was not present.
The use of either genetically altered mice or in vivo
depletion of cellular or molecular subsets by treatment
with targeted monoclonal antibodies for these types of
studies has limitations because of functional redundanc-
ies of immune components. For example, if rotavirus res-
olution or protection from reinfection occurs in B-cell-
deficient mice, it demonstrates only that these functions
do not require antibody; it does not imply that antibody
would not play a role in immunologically normal mice.
The same logic would apply following depletion of spe-
cific cellular subsets. The ability of mice to resolve rotavi-
rus infection or protect against subsequent infection fol-
lowing depletion suggests only that the depleted cells
were not necessary for the function in question; they may
still be involved when present.
FIG. 6. Effect of CD8/ cell depletion on shedding of rotavirus follow-
The importance of antibody as an effector of rotavirusing EDIM inoculation of mMT mice when initiated before virus inocula-
immunity found using JHD and mMT mice was not identi-tion. The protocol was identical to that described in the legend to Fig.
cal. JHD mice were able to resolve the initial and subse-3 except mMT mice were used instead of JHD. Significant differences
in shedding of rotavirus (average A490/mouse/day) determined each quent EDIM infections within 10 days as has been found
week following virus inoculation of five control mice (A) and five de- in normal mice following an initial EDIM infection. Unlike
pleted mice (B) were found only in Week 3 (P  0.01).
normal mice, however, JHD mice were not protected
against subsequent rotavirus challenges, even within 5
weeks of resolution of a previous infection. Thus, thea means to determine these mechanisms (Ward et al.,
1990). immune components responsible for resolution de-
creased to nonprotective titers within a short time afterOne method used to dissect mechanisms of immunity
in mice has been the use of genetically altered animals the virus infections were resolved. Because the only im-
munological abnormality known to be present in thesethat lack defined portions of the normal immune system.
In this study, we utilized two strains of mice (JHD and mice was in B cell development, these results imply that
B cell effector function, presumably antibody, was re-mMT) that through genetic manipulation had arrested B
cell development and produced no functional antibody quired for protection against rotavirus reinfection. If pro-
tection was due to antibody, it is also probable that this(Chen et al., 1993; Kitamura et al., 1991). Using JHD mice,
van der Heyde et al. (1994) demonstrated that resolution antibody, although not necessary for resolution of rotavi-
rus infection in JHD mice, could have at least participatedof acute malaria in mice was not B cell dependent. Like-
wise, Jonjic et al. (1994), using mMT mice, reported that in resolution of the initial infection had it been present.
The importance of antibody in rotavirus immunity wasantibody was not essential for resolution of primary CMV
infection, but appeared to limit virus growth during recur- even more evident with the mMT mice. Although these
mice appeared to resolve their initial EDIM infection in arent CMV infections. For our study, these two strains of
mice were inoculated with a virulent murine rotavirus to normal time (i.e., 10 days), subsequent bursts of renewed
shedding continued for up to at least 93 days after inocula-determine the importance of antibody in both resolution
of rotavirus infection and protection against reinfection. tion. Thus, antibody appeared to be required for complete
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resolution of infection within a 3-month period in these derived from C57BL/6 mice and the other 50% from the
AB-1 ES mouse stem cell line (Chen et al., 1993). CD8/mice even though a gradual resolution occurred over this
cells produced by these mice appear to play a muchperiod in its absence. Taken together, these results imply
larger role in rotavirus immunity, particularly in resolutionthat rotavirus antibody may be the most important effector
of the initial rotavirus infection. Other genetic differencesfunction involved in rotavirus immunity in mice.
in the mouse strains due either to natural mutations orIn addition to B cells, CD8/ cells were also shown to
to the manipulations performed to generate B cell defi-have an important effector function in these mice. JHD
ciencies could also have contributed to their differentmice depleted of CD8/ cells were unable to resolve ro-
responses to rotavirus infection.tavirus infection and continued to shed virus at a high
When the results of these experiments were com-level for at least 6 weeks (see Fig. 3). Thus, CD8/ cells
bined, three mechanisms of rotavirus immunity had beenwere needed to resolve rotavirus shedding following the
suggested. The primary mechanism appeared to beinitial infection of JHD mice in the absence of antibody.
through B cell activity, presumably antibody. This effectorSurprisingly, however, subsequent EDIM infections were
was found to be necessary for the normal resolution ofreadily resolved in these mice whether or not CD8/ cells
the initial infection in mMT mice and was needed to pro-had been depleted prior to reinoculation (see Figs. 4A
tect against reinfection in JHD mice. The mechanism ofand 4B). One explanation for this observation was that
protection by antibody has not been determined, but itdepletion was much more effective with naive CD8/ cells
may not be through classic neutralization. The recentthan with memory or effector CD8/ cells. If this were
report by Siadatpajouh et al. (1995) that antibody of thethe case, treatment with anti-CD8/ cell mAb could block
IgA subtype against the VP6 protein of rotavirus pre-development of effector or memory CD8/ cells when
vented murine rotavirus infection of adult mice providedgiven before the initial EDIM inoculation and prevent
direct evidence for a functional role of nonneutralizingresolution of infection. When given just before reinocula-
antibody in prevention of rotavirus infection.tion, however, when memory cells were already present,
A second and probably less important effector functionanti-CD8/ cell mAb may fail to sufficiently deplete mem-
identified in this study was CD8/ cells. This was likelyory and effector cells, thus resulting in resolution of the
due to their CTL activity which is one of the primaryviral infection. Inability to effectively deplete memory and
functions of CD8/ cells and is known to be importanteffector CD8/ cells may not have been evident if these
for immunity in many viral infections (Zinkernagel andcells were present within a larger population of naive
Doherty, 1979). Although production of memory CD8/CD8/ cells. Selective depletion of naive versus memory
cells may endure for one’s lifetime (Doherty et al., 1992;and effector cells by a mAb has been reported with CD4/
Lau et al., 1994), effector CD8/ cells are short-lived, thuscells (Weyand et al., 1989; Goldschmidt et al., 1992;
accounting for their association with resolution of theChace et al., 1994) but, to our knowledge, no such evi-
initial infection but lack of association with protectiondence exists for CD8/ cells. Clearly, there are other pos-
against reinfection. Finally, when antibody was not pres-sible scenarios which could explain why depletion of
ent and CD8/ cells were depleted, another effector func-CD8/ cells permitted resolution of EDIM infection follow-
tion appeared to come into play, at least in resolution ofing reinoculation of JHD mice. Experiments in progress
infection. This may have been CD4/ cell CTL activity orare designed to identify the correct scenario.
natural killer activity, both of which have been reportedAs previously noted, EDIM infection in mMT mice was
to play protective roles in other viral infections (Yasu-only gradually resolved following infection. However,
kawa and Zarling, 1984; Lukacher et al., 1985; Bukowskidepletion of CD8/ cells had little impact on this gradual
et al., 1985; Lindsley et al., 1986; Karupiah et al., 1990).resolution. Only during Week 3 following inoculation was
Mechanisms involving the release of antiviral cytokinesshedding significantly greater in CD8/-cell-depleted mMT
such as interferon-g and TNF-a may also play rolesmice than in nondepleted animals (see Figs. 6A and 6B).
(Ramsey et al., 1993). It is even possible that nonimmuno-In spite of this, if mice were not depleted of CD8/ cells
logical mechanisms are involved in resolution of viraluntil 46 days after their initial infection, there was a burst
shedding such as depletion of villous epithelial cells sus-of shedding which was again gradually resolved (see Figs.
ceptible to rotavirus infection. The importance of CD8/-5A and 5B). Thus, CD8/ cells were involved in the gradual
specific CTL activity and the identity of a third effectorresolution of EDIM infection in nondepleted mMT mice,
mechanism in rotavirus immunity in mice are currentlybut when mice were depleted of CD8/ cells, another im-
being investigated.munological effector function came into play.
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